Floatz logo

Docetaxel

Adverse Events

The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical SchoolSmall moleculeActive
D
30/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
95/ 100

Competitive context

3 Active assets in the Adverse Events cohort.

Asset / SponsorPhaseRating
Catequentinib
Lei Li
Phase 2CCC
Niraparib
Lei Li
Phase 2CCC
Cyclophosphamide
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
D

Same molecule, other indications

Docetaxel is also rated in:

prostate neoplasmDormant
BBB
Indicative ·
73 / 100
View asset →
pancreatic adenocarcinomaDormant
BBB
Indicative ·
72 / 100
View asset →
cancer of unknown primary siteDormant
BBB
Indicative ·
72 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →